MD
MOTT DAVID M Other
US US · SEC (Form 4)
€109,030
▲ Purchases (4 ops.)
Discover the full record of transactions filed by MOTT DAVID M. Director active across 4 companies, notably Epizyme, Inc.. In total, 18 disclosures have been recorded. Total volume traded: €2.6m. The latest transaction was disclosed on 15 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations 18 total
0182,481 shares 0
Common Stock
SEC:0001567619-22-013204:0 · 15 Jun 2022
700 shares
Common Stock
SEC:0001209191-22-038596:0 · 17 Jun 2022
08,994 shares 0
Common Stock, par value $0.0001
SEC:0000899243-22-018829:0 · 17 May 2022
€21,451 20,653 shares @ €1.0386 14.8% of flow
Common Stock, par value $0.0001
SEC:0000899243-22-013153:0 · 31 Mar 2022
€57,641 50,398 shares @ €1.1437 52.9% of flow
Common Stock
SEC:0001209191-22-012399:0 · 18 Feb 2022
Ideal exit: 15 Nov 2022 (T+270) €20,752 19,552 shares @ €1.0614 19.0% of flow
Common Stock
SEC:0001209191-22-011049:0 · 15 Feb 2022
Ideal exit: 12 Nov 2022 (T+270) €20,752 19,552 shares @ €1.0614 100.0% of flow
Common Stock
SEC:0001209191-22-011049 · 15 Feb 2022
Ideal exit: 12 Nov 2022 (T+270) €9,886 8,753 shares @ €1.1294 9.1% of flow
Common Stock
SEC:0001209191-22-009391:0 · 10 Feb 2022
Ideal exit: 7 Nov 2022 (T+270) €20,971 9,500 shares @ €2.2075 34.1% of flow
Common Stock, par value $0.0001
SEC:0000899243-22-000502 · 31 Dec 2021
€20,971 9,500 shares @ €2.2075 14.5% of flow
Common Stock, par value $0.0001
SEC:0000899243-22-000502:0 · 31 Dec 2021
€20,525 4,640 shares @ €4.4235 33.4% of flow
Common Stock, par value $0.0001
SEC:0000899243-21-038635 · 30 Sept 2021
€20,525 4,640 shares @ €4.4235 14.2% of flow
Common Stock, par value $0.0001
SEC:0000899243-21-038635:0 · 30 Sept 2021
€1m 5,728 shares @ €214.0682 0.082% mcap 100.0% of flow
Common Stock
SEC:0001209191-21-057658 · 23 Sept 2021
€1m 5,728 shares @ €214.0682 0.082% mcap 50.0% of flow
Common Stock
SEC:0001209191-21-057658:0 · 23 Sept 2021
€20,031 2,858 shares @ €7.0087 32.6% of flow
Common Stock, par value $0.0001
SEC:0000899243-21-026955 · 30 Jun 2021
€20,031 2,858 shares @ €7.0087 13.9% of flow
Common Stock, par value $0.0001
SEC:0000899243-21-026955:0 · 30 Jun 2021
08,060 shares 0
Common Stock, par value $0.0001
SEC:0000899243-21-023871 · 11 Jun 2021
08,060 shares 0
Common Stock, par value $0.0001
SEC:0000899243-21-023871:0 · 11 Jun 2021
About MOTT DAVID M David M. Mott is an executive at Epizyme, Inc.